331 related articles for article (PubMed ID: 24195777)
1. Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.
Rawluszko AA; Bujnicka KE; Horbacka K; Krokowicz P; Jagodziński PP
BMC Cancer; 2013 Nov; 13():526. PubMed ID: 24195777
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.
Huang KT; Mikeska T; Dobrovic A; Fox SB
Histopathology; 2010 Sep; 57(3):451-60. PubMed ID: 20727020
[TBL] [Abstract][Full Text] [Related]
3. The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Fox SB; Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Mele T; Dogliotti L; Bottini A; Harris AL
Breast Cancer Res; 2011 Feb; 13(1):R16. PubMed ID: 21291529
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter CpG methylation is a mechanism for impaired PHD3 expression in a diverse set of malignant cells.
Place TL; Fitzgerald MP; Venkataraman S; Vorrink SU; Case AJ; Teoh ML; Domann FE
PLoS One; 2011 Jan; 6(1):e14617. PubMed ID: 21297970
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.
Andersen S; Donnem T; Stenvold H; Al-Saad S; Al-Shibli K; Busund LT; Bremnes RM
PLoS One; 2011; 6(8):e23847. PubMed ID: 21887331
[TBL] [Abstract][Full Text] [Related]
6. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X
Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905
[TBL] [Abstract][Full Text] [Related]
7. Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.
Tarhonskaya H; Hardy AP; Howe EA; Loik ND; Kramer HB; McCullagh JS; Schofield CJ; Flashman E
J Biol Chem; 2015 Aug; 290(32):19726-42. PubMed ID: 26112411
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression Levels of the Prolyl Hydroxylase Domain Proteins
Koren A; Rijavec M; Krumpestar T; Kern I; Sadikov A; Čufer T; Korošec P
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065840
[TBL] [Abstract][Full Text] [Related]
10. [The expression of hypoxia-inducible factor-1alpha and its hydroxylases in pulmonary arteries of patient with chronic obstructive pulmonary disease].
Chen YR; Dai AG; Hu RC; Kong CC
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 May; 28(3):234-8. PubMed ID: 22860423
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element.
Metzen E; Stiehl DP; Doege K; Marxsen JH; Hellwig-Bürgel T; Jelkmann W
Biochem J; 2005 May; 387(Pt 3):711-7. PubMed ID: 15563275
[TBL] [Abstract][Full Text] [Related]
12. Decreased prolyl hydroxylase 3 mRNA expression in oncocytomas compared with clear cell renal cell carcinoma.
Kampantais S; Kounatidis I; Kotoula V; Vakalopoulos I; Gkagkalidis K; Dimitriadis G
Int J Biol Markers; 2020 Dec; 35(4):80-86. PubMed ID: 33118406
[TBL] [Abstract][Full Text] [Related]
13. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1α activity in hypoxia.
Fujita N; Markova D; Anderson DG; Chiba K; Toyama Y; Shapiro IM; Risbud MV
J Biol Chem; 2012 May; 287(20):16975-86. PubMed ID: 22451659
[TBL] [Abstract][Full Text] [Related]
14. HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
Willam C; Maxwell PH; Nichols L; Lygate C; Tian YM; Bernhardt W; Wiesener M; Ratcliffe PJ; Eckardt KU; Pugh CW
J Mol Cell Cardiol; 2006 Jul; 41(1):68-77. PubMed ID: 16765982
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-Inducible Factor 2a Expression Is Positively Correlated With Gleason Score in Prostate Cancer.
Pavlakis D; Kampantais S; Gkagkalidis K; Gourvas V; Memmos D; Tsionga A; Dimitriadis G; Vakalopoulos I
Technol Cancer Res Treat; 2021; 20():1533033821990010. PubMed ID: 33752529
[TBL] [Abstract][Full Text] [Related]
16. Differential methylation in EGLN1 associates with blood oxygen saturation and plasma protein levels in high-altitude pulmonary edema.
Sharma K; Mishra A; Singh H; Thinlas T; Pasha MAQ
Clin Epigenetics; 2022 Sep; 14(1):123. PubMed ID: 36180894
[TBL] [Abstract][Full Text] [Related]
17. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.
Dayan F; Roux D; Brahimi-Horn MC; Pouyssegur J; Mazure NM
Cancer Res; 2006 Apr; 66(7):3688-98. PubMed ID: 16585195
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].
Stolze IP; Tian YM; Appelhoff RJ; Turley H; Wykoff CC; Gleadle JM; Ratcliffe PJ
J Biol Chem; 2004 Oct; 279(41):42719-25. PubMed ID: 15302861
[TBL] [Abstract][Full Text] [Related]
19. [Reciprocal regulation between hypoxia-inducible factor-1alpha and its prolyl hydroxylases in hypoxic pulmonary hypertension rats].
Chen YR; Dai AG; Hu RC
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):668-73. PubMed ID: 17129494
[TBL] [Abstract][Full Text] [Related]
20. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.
Xue J; Li X; Jiao S; Wei Y; Wu G; Fang J
Gastroenterology; 2010 Feb; 138(2):606-15. PubMed ID: 19786027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
